Axon price target raised to $222 from $177 at Barclays

Barclays raised the firm’s price target on Axon to $222 from $177 and keeps an Overweight rating on the shares. The company delivered strong Q4 revenue, adjusted EBITDA and earnings, all materially ahead of estimates with growth in both reporting segments, the analyst tells investors in a research note.